| 24.15 Data as of May 17 | -0.48 / -1.95%Today’s Change | 18.37 Today|||52-Week Range 30.20 | +0.17% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $399.4M |
Company Description
Cynosure, Inc. develops and markets aesthetic treatment systems that are used by physicians and other practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and pigmented lesions, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce the appearance of cellulite and treat toenail fungus. It offers single energy source systems as well as workstations that incorporate two or more different types of lasers or pulsed light technologies. It also offers multiple technologies and system alternatives at a variety of price points depending primarily on the number and type of energy sources included in the system. Its newer products are designed to be easily upgradeable to add additional energy sources and hand pieces, which provide its customers with technological flexibility as they expand their practices. The company was founded on July 10, 1991 and is headquartered in Westford, MA.
Employees

Shareholders
| Other institutional | 53.41% |
| Mutual fund holders | 25.05% |
| Individual stakeholders | 19.30% |
Top Executives
| Michael R. Davin | Chairman, President & Chief Executive Officer |
| David Mackie | Executive Vice President-Operations |
| Timothy W. Baker, MBA, CPA | Chief Financial Officer, Treasurer & Executive VP |
| Rafael Sierra, PhD, MBA | Chief Technology Officer |
| William T. Kelley | Senior Vice President-International |